Aytu Bioscience Stock Today
AYTU Stock | USD 1.30 0.05 3.70% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
Aytu BioScience is selling for under 1.30 as of the 27th of February 2025; that is 3.7 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.26. Aytu BioScience has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado. The company has 6.17 M outstanding shares of which 127.72 K shares are presently shorted by private and institutional investors with about 5.65 trading days to cover. More on Aytu BioScience
Moving together with Aytu Stock
Moving against Aytu Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aytu Stock Highlights
Aytu BioScience (AYTU) is traded on NASDAQ Exchange in USA. It is located in Denver Corporate Center III, Denver, CO, United States, 80237 and employs 102 people. Aytu BioScience is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.01 M. Aytu BioScience conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 6.17 M outstanding shares of which 127.72 K shares are presently shorted by private and institutional investors with about 5.65 trading days to cover.
Aytu BioScience currently holds about 23.81 M in cash with (1.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38.
Check Aytu BioScience Probability Of Bankruptcy
Ownership Allocation30% of Aytu BioScience outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change.
Check Aytu Ownership Details
Aytu BioScience Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Aytu BioScience market risk premium is the additional return an investor will receive from holding Aytu BioScience long position in a well-diversified portfolio.
Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.34) | |||
Total Risk Alpha | (0.31) | |||
Treynor Ratio | (2.25) |
Aytu Stock Against Markets
Aytu BioScience Corporate Management
Russ McMahen | Senior Development | Profile | |
Christopher Brooke | Chief Officer | Profile | |
Margaret Cabano | Vice Operations | Profile | |
Topher Brooke | Chief Officer | Profile | |
Greg Pyszczymuka | Chief Officer | Profile |
Already Invested in Aytu BioScience?
The danger of trading Aytu BioScience is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aytu BioScience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aytu BioScience. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aytu BioScience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.